Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture

By Robertson J.S.   Cook P.   Attwell A.-M.   Williams S.P.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1583-1588

Elsevier

Access to resources Recommend Favorite

Recombinant neuraminidase vaccine protects against lethal influenza

By Deroo T.   Willy M.J.   Fiers W.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 561-569

Elsevier

Access to resources Recommend Favorite

Recombinant raccoon pox vaccine protects mice against lethal plague

By Osorio J.E.   Powell T.D.   Frank R.S.   Moss K.   Haanes E.J.   Smith S.R.   Rocke T.E.   Stinchcomb D.T.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1232-1238

Elsevier

Access to resources Recommend Favorite

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase

By Chen Z.   Kadowaki S.-E.   Hagiwara Y.   Yoshikawa T.   Matsuo K.   Kurata T.   Tamura S.-I.  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3214-3222

Elsevier

Access to resources Recommend Favorite

A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge

By Fischer L.   Le Gros F.-X.   Mason P.W.   Paoletti E.  

Vaccine, Vol. 15, Iss. 1, 1997-01 ,pp. : 90-96

Elsevier

Access to resources Recommend Favorite